These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38766737)

  • 21. Rheumatoid Arthritis Disease Activity Predicting Incident Clinically Apparent Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Prospective Cohort Study.
    Sparks JA; He X; Huang J; Fletcher EA; Zaccardelli A; Friedlander HM; Gill RR; Hatabu H; Nishino M; Murphy DJ; Iannaccone CK; Mahmoud TG; Frits ML; Lu B; Rosas IO; Dellaripa PF; Weinblatt ME; Karlson EW; Shadick NA; Doyle TJ
    Arthritis Rheumatol; 2019 Sep; 71(9):1472-1482. PubMed ID: 30951251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-cyclic citrullinated peptide antibodies, other common autoantibodies, and smoking as risk factors for lymphoma in patients with rheumatoid arthritis.
    Baecklund E; Backlin C; Rönnelid J; Toes R; Huizinga T; Åhlin E; Askling J; Hochberg FH; Klareskog L; Kay J; Smedby KE
    Scand J Rheumatol; 2018 Jul; 47(4):270-275. PubMed ID: 29336646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies to malondialdehyde-acetaldehyde modified low-density lipoprotein in patients with newly diagnosed inflammatory joint disease.
    Kononoff A; Hörkkö S; Pussinen P; Kautiainen H; Elfving P; Savolainen E; Arstila L; Niinisalo H; Rutanen J; Marjoniemi O; Kaipiainen-Seppänen O
    Scand J Rheumatol; 2021 Mar; 50(2):113-117. PubMed ID: 32985314
    [No Abstract]   [Full Text] [Related]  

  • 24. [Prevalence and significance of antibodies to citrullinated human fibrinogen β67-77 peptide in rheumatoid arthritis].
    Li GY; Sun XL; An Y; Hu FL; Li Y; Li ZG
    Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(33):2642-5. PubMed ID: 24360044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality.
    Hyldgaard C; Hilberg O; Pedersen AB; Ulrichsen SP; Løkke A; Bendstrup E; Ellingsen T
    Ann Rheum Dis; 2017 Oct; 76(10):1700-1706. PubMed ID: 28611082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions between smoking, increased serum levels of anti-CCP antibodies, rheumatoid factors, and erosive joint disease in patients with early, untreated rheumatoid arthritis.
    Krol A; Garred P; Heegaard NH; Christensen AF; Hetland ML; Stengaard-Pedersen K; Junker P; Madsen HO; Lottenburger T; Ellingsen T; Andersen LS; Hansen I; Pedersen JK; Svendsen AJ; Tarp U; Pødenphant J; Lindegaard H; Østergaard M; Hørslev-Petersen K; Jacobsen S
    Scand J Rheumatol; 2015; 44(1):8-12. PubMed ID: 25205362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison between IgG- and IgA-class antibodies to cyclic citrullinated peptides and to modified citrullinated vimentin in early rheumatoid arthritis and very early arthritis.
    Svärd A; Kastbom A; Söderlin MK; Reckner-Olsson Å; Skogh T
    J Rheumatol; 2011 Jul; 38(7):1265-72. PubMed ID: 21459947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Citrullinated and malondialdehyde-acetaldehyde modified fibrinogen activates macrophages and promotes an aggressive synovial fibroblast phenotype in patients with rheumatoid arthritis.
    Aripova N; Duryee MJ; England BR; Hunter CD; Mordeson JE; Ryan EM; Daubach EC; Romberger DJ; Thiele GM; Mikuls TR
    Front Immunol; 2023; 14():1203548. PubMed ID: 37654483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk Factors and Changes of Peripheral NK and T Cells in Pulmonary Interstitial Fibrosis of Patients with Rheumatoid Arthritis.
    Lai NL; Jia W; Wang X; Luo J; Liu GY; Gao C; Li XF; Xie JF
    Can Respir J; 2019; 2019():7262065. PubMed ID: 31885749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum rheumatoid factor IgA, anti-citrullinated peptide antibodies with secretory components, and anti-carbamylated protein antibodies associate with interstitial lung disease in rheumatoid arthritis.
    Oka S; Higuchi T; Furukawa H; Shimada K; Okamoto A; Hashimoto A; Komiya A; Saisho K; Yoshikawa N; Katayama M; Matsui T; Fukui N; Migita K; Tohma S
    BMC Musculoskelet Disord; 2022 Jan; 23(1):46. PubMed ID: 35027028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibodies against advanced glycation end-products and malondialdehyde-acetaldehyde adducts identify a new specific subgroup of hitherto patients with seronegative arthritis with a distinct clinical phenotype and an HLA class II association.
    van den Beukel MD; van Wesemael TJ; Hoogslag ATW; Borggreven NV; Huizinga TW; van der Helm-van Mil AH; Toes RE; van der Woude D; Trouw LA
    RMD Open; 2023 Dec; 9(4):. PubMed ID: 38053459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence, incidence and cause-specific mortality of rheumatoid arthritis-associated interstitial lung disease among older rheumatoid arthritis patients.
    Sparks JA; Jin Y; Cho SK; Vine S; Desai R; Doyle TJ; Kim SC
    Rheumatology (Oxford); 2021 Aug; 60(8):3689-3698. PubMed ID: 33462611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of cross-reactive antibodies targeting peptidyl-arginine deiminase 3 and 4 with rheumatoid arthritis-associated interstitial lung disease.
    Giles JT; Darrah E; Danoff S; Johnson C; Andrade F; Rosen A; Bathon JM
    PLoS One; 2014; 9(6):e98794. PubMed ID: 24901704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA.
    Agrawal S; Misra R; Aggarwal A
    Clin Rheumatol; 2007 Feb; 26(2):201-4. PubMed ID: 16572283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-agalactosyl IgG antibodies and isotype profiles of rheumatoid factors in Sjögren's syndrome and rheumatoid arthritis.
    Ichikawa Y; Yamada C; Horiki T; Hoshina Y; Uchiyama M; Yamada Y; Toumatu J
    Clin Exp Rheumatol; 1998; 16(6):709-15. PubMed ID: 9844764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rheumatoid arthritis-associated autoantibodies in non-rheumatoid arthritis patients with mucosal inflammation: a case-control study.
    Janssen KM; de Smit MJ; Brouwer E; de Kok FA; Kraan J; Altenburg J; Verheul MK; Trouw LA; van Winkelhoff AJ; Vissink A; Westra J
    Arthritis Res Ther; 2015 Jul; 17(1):174. PubMed ID: 26155788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rheumatoid Arthritis-Interstitial Lung Disease in the United States: Prevalence, Incidence, and Healthcare Costs and Mortality.
    Raimundo K; Solomon JJ; Olson AL; Kong AM; Cole AL; Fischer A; Swigris JJ
    J Rheumatol; 2019 Apr; 46(4):360-369. PubMed ID: 30442831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of disease severity measures on survival in U.S. veterans with rheumatoid arthritis-associated interstitial lung disease.
    Brooks R; Baker JF; Yang Y; Roul P; Kerr GS; Reimold AM; Kunkel G; Wysham KD; Singh N; Lazaro D; Monach PA; Poole JA; Ascherman DP; Mikuls TR; England BR
    Rheumatology (Oxford); 2022 Nov; 61(12):4667-4677. PubMed ID: 35377443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoglobulin isotypes of anti-myeloperoxidase and anti-lactoferrin antibodies in patients with collagen diseases.
    Chikazawa H; Nishiya K; Matsumori A; Hashimoto K
    J Clin Immunol; 2000 Jul; 20(4):279-86. PubMed ID: 10939715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoreactivity to malondialdehyde-modifications in rheumatoid arthritis is linked to disease activity and synovial pathogenesis.
    Grönwall C; Amara K; Hardt U; Krishnamurthy A; Steen J; Engström M; Sun M; Ytterberg AJ; Zubarev RA; Scheel-Toellner D; Greenberg JD; Klareskog L; Catrina AI; Malmström V; Silverman GJ
    J Autoimmun; 2017 Nov; 84():29-45. PubMed ID: 28647488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.